Cathepsin D Is a Potential Serum Marker for Poor Prognosis in Glioma Patients

Cancer Research - United States
doi 10.1158/0008-5472.can-04-4134
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

EZH2 Overexpression Is Associated With Poor Prognosis in Patients With Glioma

Oncotarget
Oncology
2016English

Elevated Serum Level of Angiopoietin-2 as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Serpin Peptidase Inhibitor, Clade a Member 3 (SERPINA3), Is Overexpressed in Glioma and Associated With Poor Prognosis in Glioma Patients

OncoTargets and Therapy
OncologyPharmacology
2017English

Elevated Serum Soluble Programmed Cell Death Ligand 1 Concentration as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer Patients With Chemotherapy

Respiratory Research
PulmonaryRespiratory Medicine
2018English

KPNA2 Is a Potential Diagnostic Serum Biomarker for Epithelial Ovarian Cancer and Correlates With Poor Prognosis

Tumor Biology
MedicineCancer Research
2017English

Genomic Analysis Reveals RhoC as a Potential Marker in Hepatocellular Carcinoma With Poor Prognosis

British Journal of Cancer
Cancer ResearchOncology
2004English

Serum D-Dimer Is a Potential Predictor for Thromboembolism Complications in Patients With Renal Biopsy

Scientific Reports
Multidisciplinary
2017English

Over-Expression of Cathepsin B in Hepatocellular Carcinomas Predicts Poor Prognosis of HCC Patients

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2016English

Increased Expression of Pituitary Tumor-Transforming Gene (PTTG)-1 Is Correlated With Poor Prognosis in Glioma Patients

Oncology Reports
MedicineCancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy